EMA Committee Recommends Six Drugs for Approval at October Meeting

Included are products to treat intolerance to sunlight, ovarian cancer, oestrogen deficiency and hemophilia B. Read More

Newly Combined Zimmer Biomet Announces Leadership, Organizational Structure

The changes come into effect when the merger closes in the first quarter of next year. Read More
The Solutions Center